Patents Assigned to Bioradical Research Institute Corp.
  • TEST METHOD FOR MILD COGNITIVE IMPAIRMENT, TEST REAGENT FOR MILD COGNITIVE IMPAIRMENT, AND METHOD FOR SCREENING THERAPEUTIC CANDIDATE SUBSTANCES FOR MILD COGNITIVE IMPAIRMENT
    Publication number: 20230357820
    Abstract: Provided is a test method with which mild cognitive impairment (MCI) is detectable and a measurement reagent for use in the test method. A test method for MCI according to the present invention includes a step of measuring the activity of superoxide dismutase (SOD) in a biological sample of a subject.
    Type: Application
    Filed: August 18, 2021
    Publication date: November 9, 2023
    Applicant: Bioradical Research Institute Corp.
    Inventors: Masaichi Lee, Tomoko Komatsu
  • Vasodilator and Use Thereof
    Publication number: 20230330066
    Abstract: The present invention provides a vasodilator capable of dilating a blood vessel even in the presence of ROS. A vasodilator of the present invention includes: a compound represented by the following formula (1) or a salt thereof: where in the formula (1), an A ring and a B ring may be the same or different and are each a pyrazole ring having a substituent or a pyrazoline ring having a substituent, and L is a saturated or unsaturated hydrocarbon group.
    Type: Application
    Filed: December 18, 2020
    Publication date: October 19, 2023
    Applicant: Bioradical Research Institute Corp.
    Inventor: Masaichi Lee
  • Method for Manufacturing Compound
    Publication number: 20230286921
    Abstract: The present invention provides a method for manufacturing a compound, with which it is possible to improve the yield of the compound.
    Type: Application
    Filed: July 28, 2021
    Publication date: September 14, 2023
    Applicant: Bioradical Research Institute Corp.
    Inventors: Keisuke Makino, Toshiyuki Arai, Masaichi Lee
  • Antioxidant and Use Thereof
    Publication number: 20220110916
    Abstract: The present invention provides a new antioxidant. An antioxidant of the present invention includes: a compound represented by the following formula (1) or a salt thereof: where in the formula (1), an A ring and a B ring may be the same or different and are a pyrazole ring having a substituent or a pyrazoline ring having a substituent, and L is a saturated or unsaturated hydrocarbon group.
    Type: Application
    Filed: December 18, 2019
    Publication date: April 14, 2022
    Applicant: Bioradical Research Institute Corp.
    Inventors: Keisuke Makino, Toshiyuki Arai, Yoko Arai, Masaichi Lee